To conclude, the present study demonstrated that MALAT1 silencing could suppress HPMEC apoptosis and alleviate lung injury in ARDS via the miR-150-5p-mediated ICAM-1 axis (Figure 6), indicating that targeting MALAT1 may serve as a promising therapeutic strategy for ARDS. Here, MALAT1 is linked to acute respiratory distress syndrome.